Journal of Labelled Compounds and Radiopharmaceuticals
J Label Compd Radiopharm 2007; 50: 500–501.
Published online in Wiley InterScience
JLCR
Short Research Article
Labelling of GW796406X with [M+4]-methylcoppery
ALAN H. WADSWORTH and KENNETH W. M. LAWRIE*
GlaxoSmithKline, Isotope Chemistry, Medicines Research Centre Gunnels Wood Road Stevenage SG1 2NY, UK
Received 29 August 2006; Revised 14 December 2006; Accepted 14 December 2006
Keywords: carbon-13; [13C,2H3]methyl copper; oxazolidinone; GW796406
Introduction
tic acid gave the adduct 7. Treatment with thionyl
chloride gave acid chloride 8.
A stable isotope labelled (SIL) version of GW796406X1
1 was required as a mass labelled internal standard
and a carbon-14 version 12 for ADME studies.
Compound 9 was prepared from N-Boc tyrosine
methyl ester by derivatisation of the phenolic OH group
to triflate, palladium-catalysed boronic ester forma-
tion, and periodate-assisted hydrolysis gave a boronic
acid. As 9 would eventually contain a carbon-14 label,
we optimized the coupling of the boronic acid and
pyrazole with equivalent amounts of each. Chiral HPLC
confirmed that 9 had not racemized. Condensation of 8
with amine 9 was readily carried out using Schotten-
Baumann conditions. The purified (S,S) product 10
was shown (chiral HPLC, NMR) to contain insignificant
amounts of the undesired (R,S) and (S,R) diastereoi-
somers. Alkaline hydrolysis gave the SIL-GW796406 1
after a simple work-up. The carbon-14 labelled version
12 of GW796406 was prepared similarly from N-Boc
[U-14C]tyrosine methyl ester 11.
Results and discussion
Addition of 2 equivalents of [2H3,13C]methylcopper to
the chiral N-(E)-crotonyl oxazolidinone2 3 gave clean
conversion to the required 4. The highly stereoselective
chelation-controlled aldol reaction of the titanium
enolate of imide (4) with formaldehyde trimer gave
essentially one diastereoisomer 5. Trace amounts of
the other C-2 diastereoisomer were removed during the
purification. Hydrolytic cleavage gave the acid
6
cleanly. Mitsunobu reaction of alcohol 6 with thiolace-
*Correspondence to: Kenneth W. M. Lawrie, GlaxoSmithKline, Isotope
Chemistry, Medicines Research Centre Gunnels Wood Road Stevenage
SG1 2NY, UK. E-mail: ken.w.lawrie@gsk.com
yProceedings of the Ninth Inernational Symposium on the Synthesis
and Applications of Isotopically Labelled Compounds, Edinburgh,
16–20 July 2006.
Copyright # 2007 John Wiley & Sons, Ltd.